Anne J. Gonzales-Luna, PharmD

Post-Doctoral Fellow
University of Houston
Houston, TX

Disclosure: Nothing to disclose

Presentation(s):

• 840 - Clinical Failure Rates Associated with Hemin-Induced Metronidazole Resistance in Clostridioides difficile

  Thursday, October 3
  2:30 PM – 2:45 PM

• LB7 - A Randomized, Blinded, Placebo- and Vancomycin-Controlled, First-In-Human (FIH) Study of the Safety, Pharmacokinetics (PK), and Fecal Microbiome Effects of ACX-362E, a Novel Anti-Clostridial DNA Polymerase IIIC (polIIIC) Inhibitor

  Thursday, October 3
  2:45 PM – 2:55 PM